_id
6911c5cfccc777a4e85d652c
Ticker
HLUN
Name
HEALTHeUNIVERSE Inc
Exchange
PINK
Address
1171 West San Bernardino Road, Covina, CA, United States, 91722
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various businesses in the areas of marketing, business organization, and raising capital for business ventures. The company was founded in 2001 and is headquartered in Covina, California.
Last Close
-
Volume
-
Current Price
0
Change
0
Last Updated
2026-01-04T14:32:55.193Z
Image
-
Ipo Date
-
Market Cap
1177
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2006-09-30
Revenue
150182
Cost Of Revenue
2787
Gross Profit
147395
Operating Expenses
142652
Operating Income
7530
Interest Expense
0
Pretax Income
37331
Net Income
37331
Eps
-
Dividends Per Share
0
Shares Outstanding
117775000
Income Tax Expense
0
EBITDA
-
Operating Margin
5.013916448043041
Total Other Income Expense Net
29801
Cash
38944
Short Term Investments
31860
Receivables
303397
Inventories
14000
Total Current Assets
388201
Property Plant Equipment
2249
Total Assets
393788
Payables
4422
Short Term Debt
0
Long Term Debt
0
Total Liabilities
127025
Equity
266763
Bs_currency_symbol
USD
Depreciation
674
Change In Working Capital
-
Cash From Operations
-189597
Capital Expenditures
0
Cash From Investing
208705
Cash From Financing
0
Net Change In Cash
19108
Cf_currency_symbol
USD
PE
0.01
PB
-
ROE
13.994069642341703
ROA
9.479973996160371
FCF
-189597
Fcf Percent
-1.2624482294815624
Piotroski FScore
2
Health Score
57
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
8.5
Garp Investing Score
5
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
6.5
Quality Investing Score
7
Value Investing Score
6.5
Quarters > 0 > quarter
2006-09-30
Quarters > 0 > income Statement > revenue
150182
Quarters > 0 > income Statement > cost Of Revenue
2787
Quarters > 0 > income Statement > gross Profit
147395
Quarters > 0 > income Statement > operating Expenses
142652
Quarters > 0 > income Statement > operating Income
7530
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
37331
Quarters > 0 > income Statement > net Income
37331
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
5.013916448043041
Quarters > 0 > income Statement > total Other Income Expense Net
29801
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
38944
Quarters > 0 > balance Sheet > short Term Investments
31860
Quarters > 0 > balance Sheet > receivables
303397
Quarters > 0 > balance Sheet > inventories
14000
Quarters > 0 > balance Sheet > total Current Assets
388201
Quarters > 0 > balance Sheet > property Plant Equipment
2249
Quarters > 0 > balance Sheet > total Assets
393788
Quarters > 0 > balance Sheet > payables
4422
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
127025
Quarters > 0 > balance Sheet > equity
266763
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
37331
Quarters > 0 > cash Flow > depreciation
674
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-189597
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
208705
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
19108
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
13.994069642341703
Quarters > 0 > ratios > ROA
9.479973996160371
Quarters > 0 > ratios > FCF
-189597
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-1.2624482294815624
Quarters > 0 > health Score
57
Quarters > 1 > quarter
2006-06-30
Quarters > 1 > income Statement > revenue
70398
Quarters > 1 > income Statement > cost Of Revenue
-5444
Quarters > 1 > income Statement > gross Profit
75842
Quarters > 1 > income Statement > operating Expenses
98372
Quarters > 1 > income Statement > operating Income
-27974
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-15834
Quarters > 1 > income Statement > net Income
-15834
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
0
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-39.736924344441604
Quarters > 1 > income Statement > total Other Income Expense Net
12140
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
19835
Quarters > 1 > balance Sheet > short Term Investments
240565
Quarters > 1 > balance Sheet > receivables
276027
Quarters > 1 > balance Sheet > inventories
14000
Quarters > 1 > balance Sheet > total Current Assets
550427
Quarters > 1 > balance Sheet > property Plant Equipment
2461
Quarters > 1 > balance Sheet > total Assets
556689
Quarters > 1 > balance Sheet > payables
5977
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
116157
Quarters > 1 > balance Sheet > equity
440532
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-15834
Quarters > 1 > cash Flow > depreciation
674
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-214342
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
220884
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
6543
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-3.594290539620278
Quarters > 1 > ratios > ROA
-2.8443170244068052
Quarters > 1 > ratios > FCF
-214342
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-3.0447171794653256
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2006-03-31
Quarters > 2 > income Statement > revenue
80428
Quarters > 2 > income Statement > cost Of Revenue
17753
Quarters > 2 > income Statement > gross Profit
62675
Quarters > 2 > income Statement > operating Expenses
116993
Quarters > 2 > income Statement > operating Income
-36565
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-13736
Quarters > 2 > income Statement > net Income
-13736
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-45.463022827870894
Quarters > 2 > income Statement > total Other Income Expense Net
22829
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
13293
Quarters > 2 > balance Sheet > short Term Investments
461449
Quarters > 2 > balance Sheet > receivables
365897
Quarters > 2 > balance Sheet > inventories
16475
Quarters > 2 > balance Sheet > total Current Assets
857114
Quarters > 2 > balance Sheet > property Plant Equipment
2670
Quarters > 2 > balance Sheet > total Assets
864050
Quarters > 2 > balance Sheet > payables
9987
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
189194
Quarters > 2 > balance Sheet > equity
674856
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-13736
Quarters > 2 > cash Flow > depreciation
675
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
417258
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-431449
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-14192
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-2.035397181028249
Quarters > 2 > ratios > ROA
-1.5897228169666107
Quarters > 2 > ratios > FCF
417258
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
5.187969363903118
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2005-12-31
Quarters > 3 > income Statement > revenue
180779
Quarters > 3 > income Statement > cost Of Revenue
3538
Quarters > 3 > income Statement > gross Profit
177241
Quarters > 3 > income Statement > operating Expenses
104078
Quarters > 3 > income Statement > operating Income
76701
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
75249
Quarters > 3 > income Statement > net Income
35042
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
40207
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
42.42804750551778
Quarters > 3 > income Statement > total Other Income Expense Net
-1452
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
27485
Quarters > 3 > balance Sheet > short Term Investments
30000
Quarters > 3 > balance Sheet > receivables
339897
Quarters > 3 > balance Sheet > inventories
14000
Quarters > 3 > balance Sheet > total Current Assets
411382
Quarters > 3 > balance Sheet > property Plant Equipment
2881
Quarters > 3 > balance Sheet > total Assets
418993
Quarters > 3 > balance Sheet > payables
6716
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
260620
Quarters > 3 > balance Sheet > equity
158373
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
35042
Quarters > 3 > cash Flow > depreciation
834
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-59175
Quarters > 3 > cash Flow > capital Expenditures
1
Quarters > 3 > cash Flow > cash From Investing
54499
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-4676
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
22.12624626672476
Quarters > 3 > ratios > ROA
8.363385545820574
Quarters > 3 > ratios > FCF
-59176
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.3273389055144679
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2005-12-31
Annuals > 0 > income Statement > revenue
524509
Annuals > 0 > income Statement > cost Of Revenue
38450
Annuals > 0 > income Statement > gross Profit
486059
Annuals > 0 > income Statement > operating Expenses
384548
Annuals > 0 > income Statement > operating Income
139961
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
130096
Annuals > 0 > income Statement > net Income
88289
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
0
Annuals > 0 > income Statement > income Tax Expense
41807
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
26.684194170166762
Annuals > 0 > income Statement > total Other Income Expense Net
-9865
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
27485
Annuals > 0 > balance Sheet > short Term Investments
30000
Annuals > 0 > balance Sheet > receivables
339897
Annuals > 0 > balance Sheet > inventories
14000
Annuals > 0 > balance Sheet > total Current Assets
411382
Annuals > 0 > balance Sheet > property Plant Equipment
2881
Annuals > 0 > balance Sheet > total Assets
418993
Annuals > 0 > balance Sheet > payables
6716
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
260620
Annuals > 0 > balance Sheet > equity
158373
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
88289
Annuals > 0 > cash Flow > depreciation
6920
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-57769
Annuals > 0 > cash Flow > capital Expenditures
13808
Annuals > 0 > cash Flow > cash From Investing
-43808
Annuals > 0 > cash Flow > cash From Financing
129000
Annuals > 0 > cash Flow > net Change In Cash
27423
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
55.74750746655048
Annuals > 0 > ratios > ROA
21.071712415243212
Annuals > 0 > ratios > FCF
-71577
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.1364647699086193
Annuals > 0 > health Score
46
Annuals > 1 > quarter
2004-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-6392
Annuals > 1 > income Statement > gross Profit
6392
Annuals > 1 > income Statement > operating Expenses
8980
Annuals > 1 > income Statement > operating Income
-8980
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-8980
Annuals > 1 > income Statement > net Income
-5921
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
0
Annuals > 1 > income Statement > income Tax Expense
-3059
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
0
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7150
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
6521
Annuals > 1 > balance Sheet > total Current Assets
17530
Annuals > 1 > balance Sheet > property Plant Equipment
217
Annuals > 1 > balance Sheet > total Assets
18747
Annuals > 1 > balance Sheet > payables
9100
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
12005
Annuals > 1 > balance Sheet > equity
6742
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5921
Annuals > 1 > cash Flow > depreciation
473
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
2040
Annuals > 1 > cash Flow > capital Expenditures
13808
Annuals > 1 > cash Flow > cash From Investing
-43808
Annuals > 1 > cash Flow > cash From Financing
1211
Annuals > 1 > cash Flow > net Change In Cash
3251
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-87.82260456837734
Annuals > 1 > ratios > ROA
-31.58372006187657
Annuals > 1 > ratios > FCF
-11768
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
21
Annuals > 2 > quarter
2003-12-31
Annuals > 2 > income Statement > revenue
281
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
281
Annuals > 2 > income Statement > operating Expenses
19472
Annuals > 2 > income Statement > operating Income
-19191
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-19191
Annuals > 2 > income Statement > net Income
-16132
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
-3059
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-6829.537366548043
Annuals > 2 > income Statement > total Other Income Expense Net
0
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
52
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
12913
Annuals > 2 > balance Sheet > total Current Assets
16824
Annuals > 2 > balance Sheet > property Plant Equipment
222
Annuals > 2 > balance Sheet > total Assets
18046
Annuals > 2 > balance Sheet > payables
9100
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
11304
Annuals > 2 > balance Sheet > equity
6742
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-16132
Annuals > 2 > cash Flow > depreciation
494
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-21228
Annuals > 2 > cash Flow > capital Expenditures
13808
Annuals > 2 > cash Flow > cash From Investing
-43808
Annuals > 2 > cash Flow > cash From Financing
19000
Annuals > 2 > cash Flow > net Change In Cash
-2228
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-239.2761791753189
Annuals > 2 > ratios > ROA
-89.39377147290259
Annuals > 2 > ratios > FCF
-35036
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-124.68327402135232
Annuals > 2 > health Score
20
Annuals > 3 > quarter
2002-12-31
Annuals > 3 > income Statement > revenue
3577
Annuals > 3 > income Statement > cost Of Revenue
4823
Annuals > 3 > income Statement > gross Profit
-1246
Annuals > 3 > income Statement > operating Expenses
8665
Annuals > 3 > income Statement > operating Income
-5088
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-5793
Annuals > 3 > income Statement > net Income
-6593
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
800
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-142.2421023203802
Annuals > 3 > income Statement > total Other Income Expense Net
-705
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2280
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
12913
Annuals > 3 > balance Sheet > total Current Assets
15193
Annuals > 3 > balance Sheet > property Plant Equipment
316
Annuals > 3 > balance Sheet > total Assets
16909
Annuals > 3 > balance Sheet > payables
0
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
13035
Annuals > 3 > balance Sheet > equity
3874
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6593
Annuals > 3 > cash Flow > depreciation
482
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-11475
Annuals > 3 > cash Flow > capital Expenditures
215
Annuals > 3 > cash Flow > cash From Investing
-215
Annuals > 3 > cash Flow > cash From Financing
10000
Annuals > 3 > cash Flow > net Change In Cash
-1690
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-170.18585441404232
Annuals > 3 > ratios > ROA
-38.99106984446153
Annuals > 3 > ratios > FCF
-11690
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.268101761252446
Annuals > 3 > health Score
11
Valuation > metrics > PE
0.01
Valuation > final Score
70
Valuation > verdict
99.9% Undervalued
Profitability > metrics > ROE
13.994069642341703
Profitability > metrics > ROA
9.61641005561552
Profitability > metrics > Net Margin
0.24857173296400367
Profitability > final Score
87
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.4761717329614677
Risk > metrics > Interest Coverage
0.25267608469514447
Risk > final Score
61
Risk > verdict
High
Liquidity > metrics > Current Ratio
87.78855721393035
Liquidity > metrics > Quick Ratio
84.62256897331524
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
95
Prev Risks > 0
51
Prev Risks > 1
54
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:58:34.476Z
Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various businesses in the areas of marketing, business organization, and raising capital for business ventures. The company was founded in 2001 and is headquartered in Covina, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStockWatch: Avadel Sparks Bidding War; Agios Plummets 51% on Phase III Data Genetic Engineering and Biotechnology News
Read more →Showing 2 of 7
(Last Updated 2006-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of HEALTHeUNIVERSE Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2006-09-30)
(Last Updated 2006-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2006-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2006-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.